About This Site
Editorial Standards & Methodology
How BetterNewLives.com researches, grades, and maintains its guides — and the commercial relationships we disclose so you can weigh them yourself.
John Jensen — California Attorney
John Jensen is a California-licensed attorney with a practice background in employment, administrative, business, and AI law. He is the founder of BetterNewLives.com and NextLaw.pro.
He built BetterNewLives.com after seeing how difficult it was for consumers and researchers to find straight answers about GLP-1 pricing, insurance coverage, compounding safety, and research peptide quality — topics where information online ranges from promotional to actively misleading, and where supplier-funded content had quietly become dominant.
His legal background shapes how this site approaches regulatory context, insurance navigation, and consumer protection topics. The guides on insurance appeals, prior authorization, compounding pharmacy safety, and telehealth fraud reflect direct familiarity with how those systems work — not generic summaries of press releases.
Not medical advice. John Jensen is not a medical professional. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is for informational, research, and educational purposes only. Always consult a licensed healthcare provider before making health decisions.
Every factual claim in BetterNewLives.com guides is tagged with an evidence grade. This reflects the quality, volume, and consistency of the research supporting that specific claim — not the overall credibility of the topic. A peptide can have Strong evidence for one effect and Limited evidence for another.
The grading system is designed to give you calibrated uncertainty — to distinguish what is well-established from what is speculative, so you can weight the information appropriately. We do not round up evidence to make content more persuasive, and we do not omit "Limited" grades to avoid undermining a topic we cover.
| Grade | What It Means | Typical Basis |
|---|---|---|
| Strong | Multiple large, well-designed randomized controlled trials (RCTs) with consistent findings; sufficient evidence to guide clinical practice. | Phase 3 RCTs, Cochrane meta-analyses, FDA approval endpoints, established clinical guidelines |
| Moderate | Multiple smaller or fewer large RCTs, or strong observational evidence with consistent direction. The effect is likely real but magnitude or mechanism may be uncertain. | Phase 2 RCTs, well-designed cohort studies, secondary endpoints from Phase 3 trials |
| Preliminary | Early-phase clinical trials or Phase 2 data. Promising but effect size and safety profile need further confirmation in larger trials. | Phase 1/2 trials, small RCTs (<100 participants), early mechanistic data with some human confirmation |
| Emerging | Primarily preclinical data (animal or cell studies), case reports, or observational community data. Biologically plausible but human evidence is absent or very sparse. | Animal studies, in-vitro research, case series, community-reported anecdotal patterns |
| Limited | Conflicting studies, methodological concerns, publication bias likely, or simply very few studies of any quality. Treat with significant skepticism. | Single small studies, high-ROB trials, industry-funded studies with no independent replication, theoretical only |
Source Selection
All clinical claims are sourced from primary peer-reviewed literature (PubMed, ClinicalTrials.gov), major trial publications (NEJM, JAMA, Lancet, and relevant specialty journals), and official regulatory documents (FDA approval letters, prescribing information, guidance documents). We do not treat press releases, company-sponsored blog posts, or supplement retailer "education" pages as primary sources.
For regulatory and legal context, we draw on FDA guidance documents, Federal Register notices, state pharmacy board resources, and publicly available court filings. This is an area where John Jensen's legal background provides substantive advantage over general health content.
What We Specifically Avoid
- Evidence laundering — presenting animal or in-vitro data as if it establishes human effects without flagging the gap
- Confidence inflation — using terms like "proven" or "established" for findings that are preliminary or emerging
- Safety omission — leading with benefits without proportionate treatment of known risks, side effects, and regulatory status
- Supplier capture — a supplier paying for guide content, either directly or through affiliate arrangements tied to editorial position
- SEO fiction — manufacturing FAQs around search terms without substantive underlying content
Update Policy
Guides are reviewed when significant new trial data is published, when regulatory status changes, or when we identify an error. The Last Updated date on each guide reflects the most recent content review, not just technical edits. We do not refresh dates to appear current without corresponding content review.
Pricing data in the comparison tool is updated separately from guide content — the two pipelines are independent.
What "Independent Editorial" Means Here — Specifically
In 2026, investigations exposed peptide companies manipulating Reddit, AI-generated search results, and "educational" content to promote their products. Supplier-funded guide content, undisclosed affiliate relationships, and paid ranking manipulation had become widespread in this space. BetterNewLives.com was built as a direct response to that environment.
No supplier has ever paid to influence the content of any guide on this site. No supplier has a relationship with BetterNewLives.com that gives them input into what our guides say, how evidence is graded, or which products are recommended or cautioned against. Evidence determines what guides say — suppliers do not.
This independence is not hypothetical. We have specifically declined arrangements that would have traded editorial influence for revenue, and we have written critical content about products and programs whose suppliers have advertising relationships on other parts of the internet.
Commercial Relationships We Do Have (Disclosed)
Transparency requires disclosing what commercial relationships we do have:
- No supplier placements or sponsorships: We do not sell sponsored or featured placements in the price comparison tool, and we accept no payment, commission, or sponsorship from any research peptide supplier. Rows rank by price only.
- Amazon affiliate links: BetterNewLives.com is a participant in the Amazon Services LLC Associates Program. When you purchase a supplement or product through an Amazon link on this site, we may earn a small commission at no extra cost to you. This affiliate relationship applies only to Amazon product links; we have no affiliate relationship with any research peptide supplier or telehealth company.
- Display advertising: We may display general advertising on some pages. Ad networks do not influence editorial content.
These commercial relationships fund site operations. They do not extend to guide content, and no supplier in any of these categories has editorial input into what guides say.
How Prices Are Collected
Research peptide and supplement prices are collected through an automated scraper that pulls current listings directly from supplier websites. Prices are timestamped at capture so you can see exactly when each data point was recorded.
Our pipeline includes an outlier-detection step: if any price changes by more than 25% from the last run, it is held for human review before going live. This catches both scraper errors and genuine large price movements that deserve a second look before publication.
- Scraped prices are marked with the capture date and show the price listed by the supplier at that moment.
- Amazon prices are maintained as a static reference from data.js — Amazon blocks automated scrapers. These reflect listed prices at the time of last manual update.
- Prices change frequently. Always confirm the current price directly with the supplier before purchasing. BetterNewLives.com is not responsible for price discrepancies between what is shown here and what a supplier charges.
Independence & Ownership
BetterNewLives.com is independent. It is not affiliated with, owned by, or financially connected to any peptide supplier, telehealth company, compounding pharmacy, pharmaceutical manufacturer, or wellness brand. The site was built and is maintained by John Jensen as an independent project.
If you see something on this site that appears to conflict with these editorial standards — a claim that seems overstated, an omission of known risk, or a commercial relationship that isn't disclosed — please let us know. We take corrections seriously.
Questions, Corrections & Advertising
For data errors, guide corrections, or advertising inquiries:
[email protected]We typically respond within 1–2 business days. For corrections, please include the URL of the page and a description of the issue. Confirmed errors are corrected promptly and noted in the guide's update history.
Browse the full guide library — GLP-1 medications, research peptides, supplements, and consumer tools.
View All Guides →